key: cord-0762432-2oam6stp authors: Leka, Kristi; Hamann, Carla; Desdemoustier, Pauline; Frédérich, Michel; Garigliany, Mutien‐Marie; Ledoux, Allison title: In vitro antiviral activity against SARS‐CoV‐2 of common herbal medicinal extracts and their bioactive compounds date: 2022-04-09 journal: Phytother Res DOI: 10.1002/ptr.7463 sha: 4c98e173542b30ccee5fa30fb5cf37d791f3a274 doc_id: 762432 cord_uid: 2oam6stp nan To the Editor, The coronavirus SARS-CoV-2 spread all around the world, leading to an unprecedented pandemic. Up to date, some effective treatments have been highlighted to treat the symptoms, but not to cure the COVID-19 disease. At least, some well-known medicines have been proposed, but have rapidly become the subject of some controversy, such as hydroxychloroquine combined or not azithromycin (Maisonnasse et al., 2020; Okour, Al-Kofahi, & Austin, 2020) and ivermectin (Zaidi & Dehgani-Mobaraki, 2022) . As no treatments were considered neither safe nor efficient enough, new coronavirus vaccines obtained conditional marketing authorisation. The public health crisis of COVID-19 led to countries around the world promoting massive vaccination programs. However, one can observe that the results are not fulfilling the hopes and expectations concerning virus transmission (Franco-Paredes, 2022) , while the data concerning pharmacovigilance are still in process. In this context, research should focus on the hindrances of implementing cost-effective and safe drugs, as well as preventive health products. Plants extracts and natural isolated compounds which are already used as medicines, dietary supplements or preventive health products, can offer a cost-effective way to fight against COVID-19, especially since they have proven to be safe to use. In accordance with this strategy, we have then evaluated different For raw herbal materials, ethanol crude extracts were prepared by maceration of powdered plant with EtOH at room temperature. A 10 g of dried powder was used for 100 ml of EtOH. The solvent of the resulting filtrates was evaporated at low temperature (<40 C) under reduced pressure and dissolved in DMSO. Commercially manufactured extracts were readily dissolved in DMSO for the assay. Cells culture and virus preparation were performed as previously described by our team (Ledoux et al., 2022) . The antiviral and cytotoxic experiments were performed in triplicate in 96-well plates, as previously reported (Ledoux et al., 2022) . On day one, cells grown in (Table 1) . Regarding this high potential, the most important bioactive compound from C. longa, as well as its metabolites have been investigated: curcumin, tetrahydrocurcumin and hexahydrocurcumin. Curcumin induced a protective effect at a concentration between 1.56 and 3.125 μg/ml (4.2-8.5 μM), so there is no doubt that curcumin is the main active compound responsible for the antiviral activity of the tested C. longa extract. Furthermore, its two main metabolites, The authors declare no conflicts of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request. A role for quercetin in coronavirus disease 2019 (COVID-19) Transmissibility of SARS-CoV-2 among fully vaccinated individuals. The Lancet Infectious Diseases In vitro antiviral activity against SARS-CoV-2 of 28 Strychnos extracts Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome Oral nano-curcumin formulation efficacy in management of mild to moderate hospitalized coronavirus disease-19 patients: An open label nonrandomized clinical trial Curcumin, a traditional spice component, can hold the promise against COVID-19? Naringenin, a flavanone with antiviral and anti-inflammatory effects: A promising treatment strategy against COVID-19 Potential effects of curcumin in the treatment of COVID-19 infection The mechanisms of action of ivermectin against SARS-CoV-2-An extensive review. The Journal of Antibiotics The authors thank the Belgian pharmaceutical laboratory Tilman SA for giving us the plant materials. This work was supported by the Fondation Hospitalo Universitaire Léon Fredericq (FHULF, University of Liège).